Brief news reports on Tuberculosis

First ever civil society march held at the Union World Conference on Lung Health

Some 100 TB activists marched through the Kuala Lumpur Convention Centre, demanding more ambitious targets for stopping TB, the funding to meet those targets and an end to the use of detrimental language in the TB community.

Read More →

Tuberculosis Research and Development: 2012 Report on Tuberculosis Research Funding Trends: 2005-2011

Treatment Action Group and the Stop TB Partnership issue update on 2011 global TB R&D investment trends; 2011 funding increases 3% to US$649.6 million, but annual US$1.35 billion funding gap remains.

Read More →

Desmond Tutu TB Centre receives Stop TB Partnership Kochon Prize

13 November 2012 - Kuala Lumpur, Malaysia - The Desmond Tutu TB Centre at Stellenbosch University in South Africa’s Western Cape is the winner of this year’s Kochon Prize. The centre is named for its patron, Archbishop Emeritus Desmond Tutu, who had tuberculosis (TB) as a child and has throughout his lifetime advocated on behalf of people affected by TB. The centre is being honoured today for its ground-breaking research on childhood TB and for pioneering community-based approaches to TB and HIV care.

Read More →

ACTION: Children and tuberculosis: From neglect to action

ACTION has released its second brief on children and TB, issuing recommendations for the international community and affected countries to combat this neglected epidemic.

Read More →

Bi-directional TB diabetes screening in India and China

The International Union Against Tuberculosis and Lung Disease (The Union), the World Health Organization (WHO) and the World Diabetes Foundation in association with the Indian government conducted a pilot project this year screening more than 8,000 tuberculosis patients for diabetes, and over 10,000 diabetes patients per quarter for TB. Fasting blood glucose tests for diabetes measured in TB patients at 7 tertiary hospitals and over 60 primary health care centres across the country showed that 13% of them had high blood sugar levels indicating diabetes, with higher rates in the south than in the north. Interim data from the project was presented to India's Revised National TB Control Programme in September 2012 and resulted in a national policy decision to scale up testing of all TB patients for diabetes in the country.

Read More →

Give TB a human face and not mere statistics

(Hara Mihalea is a noted Public Health and Tuberculosis Consultant. She is a Greek American and trained as a specialist on adolescent reproductive health. She has worked on all aspects of public health and was one of first groups of people in 1985 that were trained as HIV counsellors at CDC. Then in 1995 she moved to Thailand and has since dedicated her life solely to the cause of TB prevention, care and control. This is based on an interview she granted to CNS onsite at the 43rd Union World Conference on Lung Health in Kula Lumpur.)

Read More →

EU health cooperation: Room for improvement

The European Union’s global plan for health, development cooperation includes the commitment that high-quality medicines and care in the developing world be available without restrictions. As such, despite its growing impact and strong investment in product R&D, the plan seemingly lacks adequate coherence, innovative financing, and coordination, collaboration with concerned parties. Filling these gaps would be a matter of priority and a way for the EU to achieve indisputable field leadership.

Read More →

Fluoroquinolone resistance worsens outcomes in MDR-TB

Multidrug-resistant tuberculosis (MDR-TB) has a worse prognosis if patients are resistant to fluoroquinolones, new analysis suggests.

Read More →

India wages hi-tech war on ancient TB scourge

NEW DELHI: Shammo Khan walks into a dusty courtyard that reeks of garbage, searching for the fingerprint of a man exhausted by HIV, drug withdrawal and the tuberculosis lesions hijacking his lungs.

Read More →

Tuberculosis protein structure defined

Researchers in the Department of Biophysics and Biophysical Chemistry at the Hopkins School of Medicine have discovered the structure of a protein integral to the drug resistance of Mycobacterium tuberculosis infections. This information can provide essential insight into drug design that would inhibit the function of this protein and hopefully increase treatment successes.

Read More →

Page 486 of 588 · Total posts: 10

←First 485 486 487 Last→